English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 20 Help

Selected(0)Clear Items/Page:    Sort:
Marine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options Journal article
Ahmed, Salman, Alam, Waqas, Aschner, Michael, Filosa, Rosanna, Cheang, Wai San, Jeandet, Philippe, Saso, Luciano, Khan, Haroon. Marine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options[J]. Cancers, 2023, 15(9).
Authors:  Ahmed, Salman;  Alam, Waqas;  Aschner, Michael;  Filosa, Rosanna;  Cheang, Wai San; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:4.5/4.9 | Submit date：2024/01/10
antimetastatic  apoptosis  autophagy  cell cycle arrest  marine cyanopeptides  
Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis Journal article
Huimin Zou, Qing Lei, Xin Yan, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu. Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis[J]. Cancers, 2022, 15(1), 260.
Authors:  Huimin Zou;  Qing Lei;  Xin Yan;  Yunfeng Lai;  Carolina Oi Lam Ung; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:4.5/4.9 | Submit date：2023/02/08
Advanced Hepatocellular Carcinoma  Clinical Outcomes  First-line  Immune Checkpoint Inhibitors  Meta-analysis  
Efficacy and Safety of First-Line Targeted Treatment and Immunotherapy for Patients with Biliary Tract Cancer: A Systematic Review and Meta-Analysis Journal article
Xin Yan, Huimin Zou, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu. Efficacy and Safety of First-Line Targeted Treatment and Immunotherapy for Patients with Biliary Tract Cancer: A Systematic Review and Meta-Analysis[J]. Cancers, 2022, 15(1), 39.
Authors:  Xin Yan;  Huimin Zou;  Yunfeng Lai;  Carolina Oi Lam Ung;  Hao Hu
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:4.5/4.9 | Submit date：2023/02/08
Biliary Tract Cancer  Cholangiocarcinoma  Immunotherapy  Targeted Therapy  
Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy Journal article
Xiang, Feifan, Liu, Huipan, Deng, Jia, Ma, Wenzhe, Chen, Yue. Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy[J]. Cancers, 2022, 14(23).
Authors:  Xiang, Feifan;  Liu, Huipan;  Deng, Jia;  Ma, Wenzhe;  Chen, Yue
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:4.5/4.9 | Submit date：2023/01/30
Denosumab  Dose  Duration Of Therapy  Giant Cell Tumor Of Bone  
Recent Advances in Bacteria-Based Cancer Treatment Journal article
Xianyuan wei, Zhen Yuan. Recent Advances in Bacteria-Based Cancer Treatment[J]. Cancers, 2022, 14(19), 4945.
Authors:  Xianyuan wei;  Zhen Yuan
Adobe PDF | Favorite |   IF:4.5/4.9 | Submit date：2023/08/28
Tumor Therapy  Engineered Bacteria  Bacteria-based Cancer Treatment  
Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies Review article
2022
Authors:  Wang, Jing;  Luo, Zhijie;  Lin, Lizhu;  Sui, Xinbing;  Yu, Lili; et al.
Favorite | TC[WOS]:45 TC[Scopus]:54  IF:4.5/4.9 | Submit date：2022/11/07
Lung Cancer  Anoikis  Apoptosis  Neoplasm Metastasis  Molecular Mechanism Therapy  
Recent Advances in Bacteria-Based Cancer Treatment Review article
2022
Authors:  Wei, Xianyuan;  Du, Meng;  Chen, Zhiyi;  Yuan, Zhen
Favorite | TC[WOS]:15 TC[Scopus]:17  IF:4.5/4.9 | Submit date：2022/11/07
Tumor Therapy  Engineered Bacteria  Bacteria-based Cancer Treatment  
Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies Journal article
Wang Jing, Luo ZhiJie, Lin LiZhu, Sui XinBing, Lili Yu, Xu Cong, Zhang RuoNan, Zhao ZiMing, Zhu QianRu, An Bo, Wang Qiao, Chen Bi, Leung Elaine Lai Han, Wu QiBiao. Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies[J]. Cancers, 2022.
Authors:  Wang Jing;  Luo ZhiJie;  Lin LiZhu;  Sui XinBing;  Lili Yu; et al.
Favorite |   IF:4.5/4.9 | Submit date：2023/06/15
Targeting cd82/kai1 for precision therapeutics in surmounting metastatic potential in breast cancer Review article
2021
Authors:  Viera, Maximillian;  Yip, George Wai Cheong;  Shen, Han Ming;  Baeg, Gyeong Hun;  Bay, Boon Huat
Favorite | TC[WOS]:2 TC[Scopus]:4  IF:4.5/4.9 | Submit date：2021/11/30
Metastasis Suppressor  Tetraspanins  Tyrosine Kinase Inhibitors  Etoposide  Cd82 Mimics  Epigenetic Drugs  
Nuclear hkii–p-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer Journal article
Han, Chae Young, Patten, David A., Kim, Se Ik, Lim, Jung Jin, Chan, David W., Siu, Michelle K.Y., Han, Youngjin, Carmona, Euridice, Parks, Robin J., Lee, Cheol, Di, Li Jun, Lu, Zhen, Chan, Karen K.L., Ku, Ja Lok, Macdonald, Elizabeth A., Vanderhyden, Barbara C., Mes-Masson, Anne Marie, Ngan, Hextan Y.S., Cheung, Annie N.Y., Song, Yong Sang, Bast, Robert C., Harper, Mary Ellen, Tsang, Benjamin K.. Nuclear hkii–p-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer[J]. Cancers, 2021, 13(14), 3399.
Authors:  Han, Chae Young;  Patten, David A.;  Kim, Se Ik;  Lim, Jung Jin;  Chan, David W.; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.5/4.9 | Submit date：2021/12/08
Cancer Metabolism  Chemoresistance  Epithelial Ovarian Cancer  Hexokinase Ii  P-p53 (Ser15)